- In March 2024, the EPA and DHA omega-3 ingredients market experienced notable growth as companies ramped up efforts to strengthen algae-based supply chains, responding to rising demand for plant-based and sustainable alternatives. Traditional marine sources such as fish oil face sustainability challenges and supply constraints, prompting innovation in microalgae cultivation and extraction technologies. Algal-origin omega-3s offer equivalent health benefits to fish-derived EPA and DHA, while supporting environmental goals and appealing to eco-conscious consumers—with 64% reportedly preferring plant-based options
- In October 2023, DSM-Firmenich unveiled Life’s OMEGA 03020, a breakthrough single-source algal omega-3 supplement designed to match the EPA: DHA ratio found in traditional fish oil—while offering twice the potency. Produced via precision fermentation in a controlled, non-GMO environment, it ensures purity and zero impact on marine ecosystems. This innovation provides supplement brands with a sustainable alternative to fish-based omega-3s, supporting cardiovascular, brain, and eye health. Life’s OMEGA 03020 reflects DSM-Firmenich’s commitment to expanding plant-based nutrition and addressing global omega-3 deficiencies with high-performance, eco-conscious solutions
- In September 2023, Aker BioMarine partnered with Swisse to launch Swisse Ultiboost High Strength Krill Oil, which was officially listed in Australia’s Listed Assessed medicine category. This designation by the Therapeutic Goods Administration (TGA) confirms the product’s efficacy for two exclusive indications: reducing knee pain and stiffness and improving physical function in cases of mild to moderate osteoarthritis. The formulation features Aker BioMarine’s Superba™ Boost Krill Oil, a phospholipid-based omega-3 source backed by extensive clinical research, including a trial conducted by CSIRO involving 235 participants. This milestone underscores the growing demand for evidence-based, krill-derived omega-3 supplements in the therapeutic space
- In May 2023, Nuseed Global launched Nutriterra, a groundbreaking plant-based omega-3 oil developed from proprietary Omega-3 Canola. Tailored for the human nutrition and dietary supplement markets, Nutriterra delivers a complete omega-3 profile—DHA, EPA, and ALA—comparable to marine oils, but with twice the ALA of conventional canola. Backed by clinical trials confirming its safety and efficacy, Nutriterra offers a sustainable alternative to fish-derived omega-3s, addressing growing consumer demand for eco-friendly, non-marine sources. Available in formats such as softgels, powders, and liquids, it supports cardiovascular, cognitive, and prenatal health while reducing pressure on ocean ecosystems
- In March 2023, Epax unveiled a upgrade to its facility in Ålesund, Norway, introducing advanced molecular distillation technology to elevate the production of ultra-concentrated omega-3 ingredients. Central to this investment is EQP+Tech, a proprietary process that separates and concentrates individual fatty acids from fish oil without excessive heat or harsh chemicals. This innovation enables Epax to maintain a 90% minimum triglyceride content across its EPA and DHA products, while improving purity, consistency, and sensory properties. The upgrade reflects Epax’s commitment to quality, sustainability, and next-generation omega-3 solutions
